Serum Sphingosine‐1‐Phosphate Is Decreased in Patients With Acute‐on‐Chronic Liver Failure and Predicts Early Mortality
Sphingosine‐1‐phosphate (S1P) regulates pathophysiological processes, including liver regeneration, vascular tone control, and immune response. In patients with liver cirrhosis, acute deterioration of liver function is associated with high mortality rates. The present study investigated whether seru...
Main Authors: | Victoria T. Mücke, Katharina Maria Schwarzkopf, Dominique Thomas, Marcus M. Mücke, Sabrina Rüschenbaum, Jonel Trebicka, Josef Pfeilschifter, Stefan Zeuzem, Christian M. Lange, Georgios Grammatikos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2020-10-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1561 |
Similar Items
-
Serum sphingolipid levels associate with upcoming virologic events and HBV genotype D in a cohort of patients with HBeAg-negative HBV infection.
by: Victoria Therese Mücke, et al.
Published: (2018-01-01) -
Sphingosine 1-Phosphate in Renal Diseases
by: Alexander Koch, et al.
Published: (2013-05-01) -
Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis.
by: Alexander Queck, et al.
Published: (2019-01-01) -
Use of Antiplatelet Agents Is Inversely Associated With Liver Fibrosis in Patients With Cardiovascular Disease
by: Katharina Schwarzkopf, et al.
Published: (2018-12-01) -
The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses
by: Marcus M. Mücke, et al.
Published: (2017-06-01)